Febuxostat National Contract

Award Notice Posted

Solicitation number
SPE2D2-22-D-0142
Agency
Awarded
to Golden State Medical Supply, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-22-D-0142-SPE2D2-22-D-0142 Federal IDV award
Place of performance
Columbus, Ohio 43228, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical awarded contract SPE2D2-22-D-0142 to Golden State Medical Supply, Inc. on April 7, 2022, for the national supply of febuxostat tablets in 40mg and 80mg strengths. The contract, valued at approximately $73,378,778.32, covers a five-year period with provisions for annual deliveries of 30-tablet bottles, priced at $98.69 per bottle for both strengths. The pharmaceutical contract will supply febuxostat to multiple government agencies including the Department of Defense, Indian Health Service, and Bureau of Prisons, with manufacturing to be carried out by Hikma Pharmaceuticals USA, Inc. at its Columbus, Ohio facility. Subsequent contract modifications have included price adjustments and option year exercises, with the most recent modification extending the contract's second option year from April 7, 2024, through April 6, 2025.

Notice text

2 versions

Update #2 · Latest ·

FEBUXOSTAT - NATIONAL CONTRACT SPE2D2-22-D-0142

Awarded contract SPE2D2-22-D-0142 to GOLDEN STATE MEDICAL SUPPLY, INC. for 73378778.32 on 2022-04-07.

Update #1 ·

FEBUXOSTAT - NATIONAL CONTRACT SPE2D2-22-D-0142

Awarded contract SPE2D2-22-D-0142 to Golden State Medical Supply, Inc. for 73378778.32 on 2022-04-07.

Files

Notice history

Notice Type Posted
This notice Award Award Notice
Febuxostat National Contract Latest solicitation Solicitation
Febuxostat National Contract Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors